|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/513 | |
| A61K 31/675 | |||
| A61K 31/553 | |||
| A61K 9/20 | |||
| A61P 31/18 | |||
| A61K 9/24 |
| (11) | Number of the document | 3346995 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16798063.0 |
| Date of filing the European patent application | 2016-11-08 | |
| (97) | Date of publication of the European application | 2018-07-18 |
| (45) | Date of publication and mention of the grant of the patent | 2019-08-28 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/060989 |
| Date | 2016-11-08 |
| (87) | Number | WO 2017/083304 |
| Date | 2017-05-18 |
| (30) | Number | Date | Country code |
| 201562253042 P | 2015-11-09 | US | |
| 201662399999 P | 2016-09-26 | US |
| (72) |
HONG, Lei, US
COLLMAN, Benjamin, Micah, US
KOZIARA, Joanna, M., US
|
| (73) |
Gilead Sciences, Inc.,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |
| THERAPEUTIC COMPOSITIONS FOR TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS |